4//SEC Filing
Rosen Robert 4
Accession 0001209191-19-060278
CIK 0001717452other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:21 PM ET
Size
5.8 KB
Accession
0001209191-19-060278
Insider Transaction Report
Form 4
Rosen Robert
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-12-10+12,500→ 12,500 totalExercise: $30.51Exp: 2029-12-10→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable as follows: (i) 50% on the date of U.S. Food and Drug Administration ("FDA") approval of tesetaxel; (ii) 25% on the first anniversary of FDA approval of tesetaxel; and (iii) 25% on the second anniversary of FDA approval of tesetaxel. Vesting is subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
Odonate Therapeutics, Inc.
CIK 0001717452
Entity typeother
Related Parties
1- filerCIK 0001555089
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:21 PM ET
- Size
- 5.8 KB